SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-056265
Filing Date
2024-05-09
Accepted
2024-05-09 07:10:38
Documents
71
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q aura-20240331.htm   iXBRL 10-Q 1846639
2 EX-10.1 aura-ex10_1.htm EX-10.1 37282
3 EX-31.1 aura-ex31_1.htm EX-31.1 17154
4 EX-31.2 aura-ex31_2.htm EX-31.2 17004
5 EX-32.1 aura-ex32_1.htm EX-32.1 15339
6 GRAPHIC img110370785_0.jpg GRAPHIC 2869
  Complete submission text file 0000950170-24-056265.txt   7679448

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT aura-20240331.xsd EX-101.SCH 1219139
74 EXTRACTED XBRL INSTANCE DOCUMENT aura-20240331_htm.xml XML 1153306
Mailing Address 80 GUEST STREET BOSTON MA 01235
Business Address 80 GUEST STREET BOSTON MA 01235 (617)500-8864
Aura Biosciences, Inc. (Filer) CIK: 0001501796 (see all company filings)

IRS No.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40971 | Film No.: 24928531
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)